Esperion Therapeutics (NASDAQ: ESPR) shares reached a new 52-week high of $27.905 after the company announced positive top-line Phase 2b results for ETC-1002.
Sagent Pharmaceuticals (NASDAQ: SGNT) shares touched a new 52-week high of $32.12...
Reis, Inc. (NASDAQ:REIS)
Q2 2014 Earnings Conference Call
July 31, 2014 11:00 AM ET
Lloyd Lynford – Chief Executive Officer
Mark Cantaluppi – Vice President and Chief Financial Officer
Rents in San Francisco are expensive, and becoming more so: REIS today put the year-over-year rise there at 6.7 percent. Middle class folks not in rent stabilized buildings are being priced out of San Francisco. What are the potential policy...
By Undiscovered Stocks:
As Reis Inc. (REIS) continues to generate significant operating leverage and begins to reaccelerate growth, the company will become a likely acquisition to a larger strategic company, such as Verisk, MSCI, or McGraw...
The U.S. office market is showing signs of picking up steam, with businesses adding space in the first quarter at the fastest pace since 2007, according to a report from real-estate data firm Reis Inc.
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.